9 Meters Biopharma Inc (NMTR) News

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14A INFORMATIONProxy Statement Pursuant to Section 14(a) of the...

Quarterly Report (10-q)

false2023Q1000155198612/310.050.05http://fasb.org/us-gaap/2022#DerivativeLiabilitiesCurrenthttp://fasb.org/us-ga...

Current Report Filing (8-k)

0001551986FALSE00015519862023-05-152023-05-15UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549   FORM...

Current Report Filing (8-k)

0001551986FALSE00015519862023-04-262023-04-260001551986dei:FormerAddressMember2023-04-262023-04-26UNITED STATESSECURITIES AND EXCHANGE...

Current Report Filing (8-k)

0001551986FALSE00015519862023-03-312023-03-31UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549   FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Current Report Filing (8-k)

0001551986FALSE00015519862023-03-282023-03-280001551986dei:FormerAddressMember2023-03-282023-03-28UNITED STATESSECURITIES AND EXCHANGE...

Current Report Filing (8-k)

0001551986FALSE00015519862023-03-132023-03-13UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549   FORM...

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Filed Pursuant to Rule 424(b)(5)  Registration Number 333-249268Prospectus supplement (To prospectus dated October 9, 2020...